Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
International Journal of Medicinal Mushrooms
Fator do impacto: 1.423 FI de cinco anos: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344

Volumes:
Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v17.i10.20
pages 921-932

Current Advances in the Antimicrobial Potential of Species of Genus Ganoderma (Higher Basidiomycetes) against Human Pathogenic Microorganisms (Review)

Mahendra K. Rai
Department of Biotechnology, SGB Amravati University, Amravati, Maharashtra-444 602, India
Swapnil Gaikwad
Department of Biotechnology, SGB Amravati University, Amravati, Maharashtra 444602, India
Dipali Nagaonkar
Department of Biotechnology, SGB Amravati University, Amravati, Maharashtra, India
Carolina Alves dos Santos
Post Graduate Program in Pharmaceutical Sciences, Department of Development and Evaluation of Bioactive Substances, University of Sorocaba, SP, Brazil

RESUMO

Ganoderma spp. are very important therapeutic mushrooms and have been used traditionally for 4000 years in the treatment of various human disorders. Different species of Ganoderma possess bioactive compounds, which have already demonstrated antiviral, antibacterial, and antifungal activities. Various bioactive compounds such as triterpenoids, colossolactones, and polysaccharides, which are responsible for the antimicrobial potential of the genus, are discussed here in detail. Some Ganoderma spp. have been reported to be potential agents for the synthesis of metal nanoparticles. These nanoparticles have demonstrated antimicrobial activity and also are reviewed herein. The main aim of this review is to discuss the possible use of Ganoderma extracts and their active principles in antimicrobial therapy.


Articles with similar content:

Algae, traditional medicine, and pharmacological advances
International Journal on Algae, Vol.10, 2008, issue 3
Samir Malhotra, Amrit Pal Singh
Medicinal Properties of the Genus Clitocybe and of Lectins from the Clouded Funnel Cap Mushroom, C. nebularis (Agaricomycetes): A Review
International Journal of Medicinal Mushrooms, Vol.18, 2016, issue 11
Jure Pohleven, Janko Kos, Jerica Sabotic
Submerged Cultivation of Medicinal Mushrooms: Bioprocesses and Products (Review)
International Journal of Medicinal Mushrooms, Vol.14, 2012, issue 3
Vladimir I. Elisashvili
Pharmacological Properties of Biocompounds from Spores of the Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes): A Review
International Journal of Medicinal Mushrooms, Vol.18, 2016, issue 9
Lucas Yamasaki Bissoqui, Vanete Thomaz Soccol, Rosalia Rubel, Luciana Porto de Souza Vandenberghe, Carlos Ricardo Soccol, Cristine Rodrigues, Fan Leifa, Sandra R.B.R. Sella
Review of Advances in Bioactive Low-Molecular-Weight Compounds, Extracts, and Biology of Phellinus sensu lato Mushrooms (Agaricomycetes) from 2011 to 2017
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 9
Ling Sun, Xiaofei Ye, Golly K. Moses, Cunshan Zhou, Henan Zhang, Mohammed A.Y. Abdualrahman, Yating Dong, Haile Ma